CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Meridian Bioscience Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Meridian Bioscience Inc
3471 River Hills Drive
Phone: (513) 271-3700p:513 271-3700 CINCINNATI, OH  45244  United States Ticker: 0K0K0K0K
This company was Merged or Acquired on 1/31/2023.
This company ceased filing statements with the SEC on 2/13/2023.
This is a Subsidiary, click here for the Parent Company
Business Summary
Meridian Bioscience, Inc. is a United States-based company. The Company is an integrated life science company that develops, manufactures, markets, and distributes a broad range of diagnostic and life science products. Its discovery and development provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. The Company's diagnosis provides diagnostic solutions in areas, including gastrointestinal and upper respiratory infections and blood lead level testing.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20229/30/2022YesYes--Yes

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3845 Electromedical and electrotherapeutic apparatus
5047 Medical, dental, and hospital equipment and supplies
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director John P.Kenny 55 10/9/2017 10/9/2017
Chief Financial Officer, Executive Vice President, Director Andrew S.Kitzmiller 43 1/31/2023 2/21/2022
Executive Vice President - Diagnostics TonySerafini - Lamanna 59 5/18/2020 5/18/2020
Executive Vice President - Life Science Lourdes G.Weltzien 57 3/1/2018 7/1/2008
Senior Vice President, Principal Accounting Officer, Controller JulieSmith 54 2/1/2022 2/1/2022

Business Names
Business Name
0K0K
Bioline (Aust) Pty Ltd.
Bioline GmbH
17 additional Business Names available in full report.

General Information
Number of Employees: 770 (As of 9/30/2022)
Outstanding Shares: 44,008,159 (As of 1/10/2023)
Shareholders: 23,850
Stock Exchange: NASD
Federal Tax Id: 310888197
Fax Number: (513) 271-3762


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024